Tri Chemical Laboratories Inc.
Tokyo Stock ExchangeTotal Valuation
Tri Chemical Laboratories Inc. carries a market capitalization of 111.79B, placing it among publicly traded companies globally. Its enterprise value stands at 113.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 111.79B |
| Enterprise Value | 113.56B |
Share Statistics
Tri Chemical Laboratories Inc. currently has 32.50M shares outstanding.
| Shares Outstanding | 32.50M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tri Chemical Laboratories Inc. trades at a trailing price-to-earnings ratio of 39.81. The price-to-sales ratio is 8.92, and the price-to-book ratio stands at 4.93.
| PE Ratio | 39.81 |
| PS Ratio | 8.92 |
| PB Ratio | 4.93 |
| P/TBV Ratio | 4.23 |
| P/FCF Ratio | 38.51 |
| P/OCF Ratio | 118.69 |
Enterprise Valuation
On an enterprise value basis, Tri Chemical Laboratories Inc. trades at an EV/EBITDA multiple of 40.75 and an EV/FCF ratio of 35.84. The EV/Sales ratio of 8.35 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 40.75 provides insight into valuation relative to core operating earnings.
| EV / Sales | 8.35 |
| EV / EBITDA | 40.75 |
| EV / EBIT | 40.75 |
| EV / FCF | 35.84 |
Financial Position
Tri Chemical Laboratories Inc. maintains a current ratio of 6.09, meaning it holds 6.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.02, indicating elevated leverage, while an interest coverage ratio of 120.98 demonstrates strong ability to service its debt obligations.
| Current Ratio | 6.09 |
| Quick Ratio | 2.95 |
| Debt / Equity | 6.02 |
| Debt / EBITDA | 0.62 |
| Interest Coverage | 120.98 |
Financial Efficiency
Tri Chemical Laboratories Inc. posts a return on equity of 12.92 and a return on invested capital of 6.93.
| Return on Equity (ROE) | 12.92 |
| Return on Assets (ROA) | 9.33 |
| Return on Invested Capital (ROIC) | 6.93 |
| Return on Capital Employed (ROCE) | 11.97 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.08 |
Taxes
Over the trailing twelve months, Tri Chemical Laboratories Inc. has paid 1.00B in income taxes, reflecting an effective tax rate of 24.74.
| Income Tax | 1.00B |
| Effective Tax Rate | 24.74 |
Stock Price Statistics
Tri Chemical Laboratories Inc.'s stock has gained approximately 6.00924% over the past 52 weeks. The 50-day moving average sits at 3,565.00, while the 200-day moving average is 3,149.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6.00924% |
| 50-Day Moving Average | 3,565.00 |
| 200-Day Moving Average | 3,149.23 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tri Chemical Laboratories Inc. generated 13.60B in revenue and converted that into 3.05B in net income, yielding earnings per share of 93.83. EBITDA reached 2.79B, while operating income came in at 2.79B.
| Revenue | 13.60B |
| Gross Profit | 5.13B |
| Operating Income | 2.79B |
| Pretax Income | 4.05B |
| Net Income | 3.05B |
| EBITDA | 2.79B |
| EBIT | 2.79B |
| Earnings Per Share (EPS) | 93.83 |
Balance Sheet
Tri Chemical Laboratories Inc. holds 9.53B in cash and equivalents against 1.73B in total debt, resulting in a net debt position of -7.80B. Total book value stands at 24.64B, with working capital of 16.44B providing operational flexibility.
| Cash & Cash Equivalents | 9.53B |
| Total Debt | 1.73B |
| Net Debt | -7.80B |
| Equity (Book Value) | 24.64B |
| Book Value Per Share | 758.37 |
| Working Capital | 16.44B |
Cash Flow
Tri Chemical Laboratories Inc. produced 1.02B in operating cash flow over the past twelve months. After subtracting -2.13B in capital expenditures, free cash flow totaled -1.11B - equivalent to -34.06 per share.
| Operating Cash Flow | 1.02B |
| Capital Expenditures | -2.13B |
| Free Cash Flow | -1.11B |
| FCF Per Share | -34.06 |
Margins
Tri Chemical Laboratories Inc. operates with a gross margin of 37.75, reflecting its pricing power and cost economics. The operating margin of 20.49 and net profit margin of 22.42 provide insight into operational efficiency.
| Gross Margin | 37.75 |
| Operating Margin | 20.49 |
| Pretax Margin | 29.79 |
| Profit Margin | 22.42 |
| EBITDA Margin | 20.49 |
Dividends & Yields
The company's payout ratio of 31.98 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 30.01 |
| Dividend Yield | N/A |
| Payout Ratio | 31.98 |
| Shareholder Yield | 1.34 |
| FCF Yield | 2.60 |
Stock Splits
Tri Chemical Laboratories Inc.'s most recent stock split took place on January 28, 2021 with a 1:4 split ratio.
| Last Split Date | 1/28/2021 |
| Split Ratio | 1:4 |
Scores
Tri Chemical Laboratories Inc. posts an Altman Z-Score of 17.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 17.47 |